[96a5a0]: / output / allTrials / identified / NCT00297648_identified.json

Download this file

272 lines (272 with data), 12.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
{
"info": {
"nct_id": "NCT00297648",
"official_title": "A Phase IIIB Multicentre Open Label 54 Weeks Clinical Trial Evaluating Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor Alpha (TNFα) on Endoscopic and Mucosal Healing in Patients Suffering From Active Crohn's Disease.",
"inclusion_criteria": "* Patients suffering from active Crohn's disease [Crohn's Disease Activity Index(CDAI) ≥ 220 and ≤ 450] and at least 2 segments with endoscopic ulcerative lesions with Baseline Crohn's Disease Endoscopic Index of Severity (CDEIS) ≥ 8\n* Patients who need to be treated by anti-tumor necrosis factor (anti-TNF) therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Obstructive intestinal strictures, bowel resection, proctocolectomy or total colectomy, current total parenteral nutrition, short bowel syndrome\n* History of tuberculosis or positive tests for tuberculosis at screening\n* All the concomitant diseases or pathological conditions that could interfere with Crohn's disease assessment or to be harmful for the well being of the patient\n* Previous clinical trials and previous biological therapy that could interfere with the results in the present clinical trial",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients suffering from active Crohn's disease [Crohn's Disease Activity Index(CDAI) ≥ 220 and ≤ 450] and at least 2 segments with endoscopic ulcerative lesions with Baseline Crohn's Disease Endoscopic Index of Severity (CDEIS) ≥ 8",
"criterions": [
{
"exact_snippets": "Patients suffering from active Crohn's disease",
"criterion": "active Crohn's disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Crohn's Disease Activity Index(CDAI) ≥ 220 and ≤ 450",
"criterion": "Crohn's Disease Activity Index (CDAI)",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 220,
"unit": "N/A"
},
{
"operator": "<=",
"value": 450,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "at least 2 segments with endoscopic ulcerative lesions",
"criterion": "segments with endoscopic ulcerative lesions",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "segments"
}
}
]
},
{
"exact_snippets": "Baseline Crohn's Disease Endoscopic Index of Severity (CDEIS) ≥ 8",
"criterion": "Baseline Crohn's Disease Endoscopic Index of Severity (CDEIS)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Patients who need to be treated by anti-tumor necrosis factor (anti-TNF) therapy",
"criterions": [
{
"exact_snippets": "Patients who need to be treated by anti-tumor necrosis factor (anti-TNF) therapy",
"criterion": "anti-tumor necrosis factor (anti-TNF) therapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Obstructive intestinal strictures, bowel resection, proctocolectomy or total colectomy, current total parenteral nutrition, short bowel syndrome",
"criterions": [
{
"exact_snippets": "Obstructive intestinal strictures",
"criterion": "obstructive intestinal strictures",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "bowel resection",
"criterion": "bowel resection",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "proctocolectomy",
"criterion": "proctocolectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "total colectomy",
"criterion": "total colectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "current total parenteral nutrition",
"criterion": "total parenteral nutrition",
"requirements": [
{
"requirement_type": "current use",
"expected_value": true
}
]
},
{
"exact_snippets": "short bowel syndrome",
"criterion": "short bowel syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of tuberculosis or positive tests for tuberculosis at screening",
"criterions": [
{
"exact_snippets": "History of tuberculosis",
"criterion": "tuberculosis",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "positive tests for tuberculosis at screening",
"criterion": "tuberculosis",
"requirements": [
{
"requirement_type": "test result",
"expected_value": "positive"
}
]
}
]
},
{
"line": "* All the concomitant diseases or pathological conditions that could interfere with Crohn's disease assessment or to be harmful for the well being of the patient",
"criterions": [
{
"exact_snippets": "concomitant diseases or pathological conditions that could interfere with Crohn's disease assessment",
"criterion": "concomitant diseases or pathological conditions",
"requirements": [
{
"requirement_type": "interference with Crohn's disease assessment",
"expected_value": true
}
]
},
{
"exact_snippets": "concomitant diseases or pathological conditions ... to be harmful for the well being of the patient",
"criterion": "concomitant diseases or pathological conditions",
"requirements": [
{
"requirement_type": "harmfulness to patient well-being",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous clinical trials and previous biological therapy that could interfere with the results in the present clinical trial",
"criterions": [
{
"exact_snippets": "Previous clinical trials",
"criterion": "previous clinical trials",
"requirements": [
{
"requirement_type": "interference",
"expected_value": true
}
]
},
{
"exact_snippets": "previous biological therapy",
"criterion": "previous biological therapy",
"requirements": [
{
"requirement_type": "interference",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}